NO179163C - Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse - Google Patents

Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse

Info

Publication number
NO179163C
NO179163C NO872991A NO872991A NO179163C NO 179163 C NO179163 C NO 179163C NO 872991 A NO872991 A NO 872991A NO 872991 A NO872991 A NO 872991A NO 179163 C NO179163 C NO 179163C
Authority
NO
Norway
Prior art keywords
preparation
release drug
sustained release
sustained
drug
Prior art date
Application number
NO872991A
Other languages
English (en)
Norwegian (no)
Other versions
NO179163B (no
NO872991D0 (no
NO872991L (no
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO872991D0 publication Critical patent/NO872991D0/no
Publication of NO872991L publication Critical patent/NO872991L/no
Publication of NO179163B publication Critical patent/NO179163B/no
Publication of NO179163C publication Critical patent/NO179163C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO872991A 1986-07-18 1987-07-17 Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse NO179163C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61167865A JPH0816066B2 (ja) 1986-07-18 1986-07-18 持続性薬効製剤

Publications (4)

Publication Number Publication Date
NO872991D0 NO872991D0 (no) 1987-07-17
NO872991L NO872991L (no) 1988-01-19
NO179163B NO179163B (no) 1996-05-13
NO179163C true NO179163C (no) 1996-08-21

Family

ID=15857516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872991A NO179163C (no) 1986-07-18 1987-07-17 Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse

Country Status (13)

Country Link
US (1) US5030455A (da)
EP (1) EP0254978B1 (da)
JP (1) JPH0816066B2 (da)
KR (1) KR960004857B1 (da)
AT (1) ATE71291T1 (da)
CA (1) CA1309656C (da)
DE (1) DE3775850D1 (da)
DK (1) DK174931B1 (da)
ES (1) ES2040228T3 (da)
FI (1) FI96095C (da)
GR (1) GR3003536T3 (da)
NO (1) NO179163C (da)
PH (1) PH25286A (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
US4975312A (en) * 1988-06-20 1990-12-04 Foster-Miller, Inc. Multiaxially oriented thermotropic polymer substrate for printed wire board
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
JP2794022B2 (ja) * 1988-11-11 1998-09-03 三生製薬株式会社 ブナゾシン或いはその塩類含有経皮適用製剤
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
GB2263910A (en) * 1992-02-05 1993-08-11 Co Ordinated Drug Dev Direct compression tablet excipient
JP2616252B2 (ja) * 1992-10-16 1997-06-04 日本新薬株式会社 ワックスマトリックスの製法
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
SG43833A1 (en) * 1993-12-13 1997-11-14 Lidak Pharmaceuticals Sucrose ester-c20 to c25 alcohol formulations
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
CA2233016C (en) * 1995-09-25 2007-07-17 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
WO1997038010A2 (en) 1996-04-11 1997-10-16 The University Of British Columbia Fusogenic liposomes
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
KR20030024191A (ko) * 2001-09-17 2003-03-26 주식회사 효성 알칼리 가용성 코폴리에스터 및 이의 제조방법
WO2003045437A1 (en) * 2001-11-30 2003-06-05 Pfizer Products Inc. Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
WO2012077750A1 (ja) * 2010-12-08 2012-06-14 アイダエンジニアリング株式会社 高強度焼結成形体の製造方法およびその製造装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895881A (en) * 1957-04-04 1959-07-21 Wynn Pharmacal Corp Quinidine gluconate sustained medication tablet
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
US4020159A (en) * 1974-10-08 1977-04-26 Apotheker A. Herbert K.G., Fabrik Pharmazeutischer Praparate Wiesbaden Methods of and medications for treating cardiac disorders by using strophanthin
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
EP0176772B1 (de) * 1984-08-30 1989-03-29 RODISMA Pharmazeutische Produkte GmbH Verfahren zur Retardierung von Vitamin C und E

Also Published As

Publication number Publication date
NO179163B (no) 1996-05-13
FI873106A0 (fi) 1987-07-14
EP0254978B1 (en) 1992-01-08
KR960004857B1 (ko) 1996-04-16
DK373187D0 (da) 1987-07-17
FI96095C (fi) 1996-05-10
DK373187A (da) 1988-01-19
CA1309656C (en) 1992-11-03
PH25286A (en) 1991-04-30
ES2040228T3 (es) 1993-10-16
FI873106L (fi) 1988-01-19
GR3003536T3 (da) 1993-03-16
JPS6327439A (ja) 1988-02-05
EP0254978A1 (en) 1988-02-03
ATE71291T1 (de) 1992-01-15
NO872991D0 (no) 1987-07-17
FI96095B (fi) 1996-01-31
US5030455A (en) 1991-07-09
NO872991L (no) 1988-01-19
DE3775850D1 (de) 1992-02-20
DK174931B1 (da) 2004-03-01
KR880001301A (ko) 1988-04-22
JPH0816066B2 (ja) 1996-02-21

Similar Documents

Publication Publication Date Title
NO179163C (no) Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
FR2612516B1 (fr) Derives de benzoxazole et preparation les contenant
GB8501015D0 (en) Drug
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
DE3883756D1 (de) Haarkosmetisches Präparat.
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
EP0283505A4 (en) Vaccine and method of preparation.
FI871313A7 (fi) Menetelmä lääkeadsorbaattien valmistamiseksi.
EP0259857A3 (en) Method of assaying physiologically active substances
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
FI875245A0 (fi) Foerfarande foer oekande av utsoendringen av adenosin.
FI873083A0 (fi) Foerfarande foer odling av bordetella pertussis, kikhostatoxoid och kikhostavaccin.
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
EP0268640A4 (en) Vaccine for stimulating or enhancing production of antibodies directed against gm2.
KR900012933A (ko) 당뇨병 및 과혈당증 치료제로 유용한 화합물 및 이의 제조방법
ATE109137T1 (de) Pyridinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE3583234D1 (de) Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.
FI871479A0 (fi) Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi
DK417889A (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
FR2630113B2 (fr) Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
FR2630114B2 (fr) Derives de (piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
FR2634204B2 (fr) Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleines, leur preparation et leur application en therapeutique
FR2619110B1 (fr) Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
OA08184A (fr) Agents anti-hypertentifs, compositions pharmaceutiques les contenant et procédé de préparation desdits agents et compositions.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: JK THORSENS PATENTBUREAU AS, POSTBOKS 9276 GRONLAN

MK1K Patent expired